Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other Operating Expenses (2025)

Adaptin Bio's (APTN) quarterly Other Operating Expenses came in at -$180000.0 in Q2 2025.

Analysis

Adaptin Bio (APTN) Other Operating Expenses (2025) Analysis & Trends

Adaptin Bio has disclosed Other Operating Expenses across 1 years of filings, most recently posting -$180000.0 for Q2 2025.

  • In Q2 2025, Other Operating Expenses changed N/A year-over-year to -$180000.0; the TTM figure through Mar 2026 stood at -$180000.0 (changed N/A YoY), while the FY2025 annual figure was -$180000.0, changed N/A from the prior year.
  • Other Operating Expenses came in at -$180000.0 for Q2 2025 at Adaptin Bio.
  • In the past five years, Other Operating Expenses ranged from a high of -$180000.0 in Q2 2025 to a low of -$180000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.26 Bn 9.41 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.18 Bn 5.18 Bn -
3 Iovance Biotherapeutics 3.82 Bn 3.52 Bn 55.72 Mn
4 Legend Biotech 3.67 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.98 Bn 1.81 Bn 56.40 Mn
10 Adaptin Bio 56.76 Mn 56.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -180,000.00